Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 2
2005 1
2006 2
2007 1
2008 1
2010 3
2011 4
2012 6
2013 6
2014 4
2015 1
2016 1
2017 2
2018 4
2019 1
2020 3
2021 3
2022 4
2023 1
Text availability
Article attribute
Article type
Publication date

Search Results

38 results
Results by year
Filters applied: . Clear all
Page 1
Glucose-6-phosphate dehydrogenase deficiency.
Luzzatto L, Ally M, Notaro R. Luzzatto L, et al. Blood. 2020 Sep 10;136(11):1225-1240. doi: 10.1182/blood.2019000944. Blood. 2020. PMID: 32702756 Free article.
G6PD deficiency makes red cells highly vulnerable to oxidative damage, and therefore susceptible to hemolysis. Over 200 G6PD mutations are known: approximately one-half are polymorphic and therefore common in various populations. Some 500 million persons with any of these …
G6PD deficiency makes red cells highly vulnerable to oxidative damage, and therefore susceptible to hemolysis. Over 200 G6PD mutation …
Review and drug therapy implications of glucose-6-phosphate dehydrogenase deficiency.
Belfield KD, Tichy EM. Belfield KD, et al. Am J Health Syst Pharm. 2018 Feb 1;75(3):97-104. doi: 10.2146/ajhp160961. Epub 2018 Jan 5. Am J Health Syst Pharm. 2018. PMID: 29305344 Review.
The most common precipitators of oxidative stress and hemolysis in G6PD deficiency include medication use and infection. CONCLUSION: G6PD deficiency should be considered in patients who experience acute hemolysis after exposure to known oxidative medications, infect …
The most common precipitators of oxidative stress and hemolysis in G6PD deficiency include medication use and infection. CONCLUSION: …
Medications and glucose-6-phosphate dehydrogenase deficiency: an evidence-based review.
Youngster I, Arcavi L, Schechmaster R, Akayzen Y, Popliski H, Shimonov J, Beig S, Berkovitch M. Youngster I, et al. Drug Saf. 2010 Sep 1;33(9):713-26. doi: 10.2165/11536520-000000000-00000. Drug Saf. 2010. PMID: 20701405 Review.
It is reasonable to conclude that, over time, many compounds have been wrongly cited as causing haemolysis because they were administered to patients experiencing an infection-related haemolytic episode. We found solid evidence to prohibit only seven currently used medicat …
It is reasonable to conclude that, over time, many compounds have been wrongly cited as causing haemolysis because they were administ …
Rasburicase Therapy and G6PD and CYB5R Genotype.
Dean L, Kane M. Dean L, et al. 2020 Sep 29. In: Pratt VM, Scott SA, Pirmohamed M, Esquivel B, Kattman BL, Malheiro AJ, editors. Medical Genetics Summaries [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2012–. 2020 Sep 29. In: Pratt VM, Scott SA, Pirmohamed M, Esquivel B, Kattman BL, Malheiro AJ, editors. Medical Genetics Summaries [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2012–. PMID: 32997466 Free Books & Documents. Review.
However, they are at risk of life-threating hemolytic reactions and methemoglobinemia if given oxidizing drugs such as rasburicase. Rasburicase is contraindicated in individuals with G6PD deficiency. ...The CPIC states for individuals with normal G6PD phenotype, the …
However, they are at risk of life-threating hemolytic reactions and methemoglobinemia if given oxidizing drugs such as rasburicase. …
Rasburicase induced severe hemolysis and methemoglobinemia in a Caucasian patient complicated by acute renal failure and ARDS.
Raru Y, Abouzid M, Parsons J, Zeid F. Raru Y, et al. Respir Med Case Rep. 2018 Dec 23;26:142-145. doi: 10.1016/j.rmcr.2018.12.011. eCollection 2019. Respir Med Case Rep. 2018. PMID: 30603605 Free PMC article.
Methemoglobinemia and hemolysis are known side effects of rasburicase that result from oxidative stress caused by hydrogen peroxide, a byproduct generated during the breakdown of uric acid to allantoin. ...It is also vital to assume a diagnosis of G6PD deficiency un …
Methemoglobinemia and hemolysis are known side effects of rasburicase that result from oxidative stress caused by hydrogen per …
Rasburicase-Induced Methemoglobinemia.
Ahmed M, Sanchez T, Norgbe S, Picking CR, Millner PG. Ahmed M, et al. Cureus. 2021 Apr 10;13(4):e14406. doi: 10.7759/cureus.14406. Cureus. 2021. PMID: 33987056 Free PMC article.
Methemoglobinemia can occur as a rare complication of treatment with rasburicase, primarily in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency. ...In patients with G6PD deficiency, methylene blue is inadequately reduced to its active form, which then caus …
Methemoglobinemia can occur as a rare complication of treatment with rasburicase, primarily in patients with glucose-6-phosphate dehy …
Rasburicase-induced haemolysis and methemoglobinemia: an ongoing issue.
Madanat L, Schoenherr D, Wey E, Gupta R. Madanat L, et al. BMJ Case Rep. 2021 Mar 16;14(3):e240967. doi: 10.1136/bcr-2020-240967. BMJ Case Rep. 2021. PMID: 33727299
We report a case of a 91-year-old Caucasian woman with a history of chronic lymphocytic leukaemia who developed acute hypoxic respiratory failure (AHRF) requiring intubation for less than 24 hours after receiving rasburicase. Laboratory workup was significant for methemogl …
We report a case of a 91-year-old Caucasian woman with a history of chronic lymphocytic leukaemia who developed acute hypoxic respiratory fa …
Rasburicase.
Easton J, Noble S, Jarvis B. Easton J, et al. Paediatr Drugs. 2001;3(6):433-7; discussion 438-9. doi: 10.2165/00128072-200103060-00004. Paediatr Drugs. 2001. PMID: 11437188
There was no evidence of renal insufficiency in 3 noncomparative trials which monitored creatinine levels to assess renal function during chemotherapy and rasburicase treatment. Rasburicase was generally well tolerated in clinical trials, with skin rashes reported i …
There was no evidence of renal insufficiency in 3 noncomparative trials which monitored creatinine levels to assess renal function during ch …
Hemolysis and methemoglobinemia secondary to rasburicase administration.
Browning LA, Kruse JA. Browning LA, et al. Ann Pharmacother. 2005 Nov;39(11):1932-5. doi: 10.1345/aph.1G272. Epub 2005 Oct 4. Ann Pharmacother. 2005. PMID: 16204390
Routine arterial blood gas analyses performed after rasburicase was administered revealed elevated methemoglobin concentrations, which peaked at 14.7%. ...DISCUSSION: Rasburicase is contraindicated in patients with G6PD deficiency as it may cause hemolytic anemia an …
Routine arterial blood gas analyses performed after rasburicase was administered revealed elevated methemoglobin concentrations, whic …
38 results